Erlotinib
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Erlotinib Product Information
Erlotinib is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Erlotinib. The product is supplied by Clearsynth under CAT No. CS-O-31362.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Erlotinib
CAS No.
183321-74-6
CAT No.
CS-O-31362
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C22H23N3O4
Molecular Weight
393.44
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Erlotinib is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Erlotinib.
Overview
"Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity (IC50 = 2.5 µM).1,2 This inhibits tumor growth in human head and neck carcinoma (HN5) tumor xenografts in mice w"
Synonyms
Erlotinib
Application Notes
"Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity (IC50 = 2.5 µM).1,2 This inhibits tumor growth in human head and neck carcinoma (HN5) tumor xenografts in mice w"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.